"Shedding"
In virology, "viral shedding" means the release of infectious virus from an infected person. In wellness-community discourse, "shedding" is sometimes used to claim that vaccinated people transmit vaccine material to nearby people. That claim is not supported by the FDA, WHO, or the peer-reviewed virology for mRNA or protein-subunit COVID-19 vaccines.
How the regulatory and peer-reviewed sources describe it
The CDC's clinical considerations for COVID-19 vaccines describe how mRNA and protein-subunit vaccines work: they do not contain live SARS-CoV-2 virus, and they cannot cause infection or be transmitted to other people. The mRNA in mRNA vaccines is degraded within days. The lipid nanoparticles do not replicate.
The FDA's COVID-19 vaccine page and the WHO's vaccine explainers address this directly. Neither agency's surveillance data has identified shedding-mediated transmission of vaccine material as a real phenomenon for these vaccine types.
The wellness-community claim sometimes points to studies showing that vaccine recipients have detectable spike protein in their bloodstream during the days following vaccination (Ogata et al., Clinical Infectious Diseases, 2021, PubMed 34015263). What these studies show is the expected pharmacokinetics — that vaccine-encoded spike is briefly detectable in the recipient's own blood — not that it transmits to other people. Confusing within-body detection with person-to-person transmission is the core scientific error of the shedding claim.
The one exception in the broader category of vaccines is live attenuated vaccines (such as the oral polio vaccine and some live-attenuated influenza vaccines), where weakened virus can in rare circumstances be shed to close contacts. This is not the case for any COVID-19 vaccine in current use.
Why this claim circulates anyway
- CDC. "Clinical Considerations for COVID-19 Vaccines." cdc.gov
- FDA. "Coronavirus (COVID-19) | CBER-Regulated Biologics." fda.gov
- Ogata AF et al. "Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients." Clinical Infectious Diseases, 2021. PubMed: 34015263
- WHO. "The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know." who.int